Patents Assigned to BIOVEN 3 LIMITED
  • Recombinant proteins and their therapeutic uses
    Patent number: 9902760
    Abstract: A recombinant protein expressing one or more human growth factors, tumor antigens, and/or receptors or epitopes thereof on or within an immunogenic expression creating a recombinant protein in which one or more epitopes are presented on the surface of the sequence in their natural configuration. The growth factor, tumor antigen, and/or receptor, sequence(s) may be expressed within the encoding sequence at appropriate internal positions or at the termini as single expressions or as two or more tandem repeats.
    Type: Grant
    Filed: November 21, 2012
    Date of Patent: February 27, 2018
    Assignee: BIOVEN 3 LIMITED
    Inventors: Keith Alan Charlton, Erik D'Hondt
  • RECOMBINANT PROTEINS AND THEIR THERAPEUTIC USES
    Publication number: 20140248302
    Abstract: A recombinant protein expressing one or more human growth factors, tumor antigens, and/or receptors or epitopes thereof on or within an immunogenic expression creating a recombinant protein in which one or more epitopes are presented on the surface of the sequence in their natural configuration. The growth factor, tumor antigen, and/or receptor, sequence(s) may be expressed within the encoding sequence at appropriate internal positions or at the termini as single expressions or as two or more tandem repeats.
    Type: Application
    Filed: November 21, 2012
    Publication date: September 4, 2014
    Applicant: BIOVEN 3 LIMITED
    Inventors: Keith Alan Charlton, Erik D'Hondt